Juno Pharmaceuticals Canada
Lynn McAllister is a seasoned professional in pharmaceutical sales and commercial operations, currently serving as the Senior Director of Commercial Operations and Quebec Liaison at Juno Pharmaceuticals Canada since October 2022, and the Owner & Founder of Rise InSpirit Academy since September 2024. Previously, Lynn held roles at Apotex Inc. as a Hospital and Specialty Sales Representative, and at Teligent, Inc. as Director of Sales. An extensive tenure at SteriMax Inc. involved positions including Senior Manager, Accounts and Customer Service, and Bilingual Senior Account Manager, focusing on account management in hospitals across Canada. Lynn's career also includes successful contributions at Starkey Hearing Technologies, Novo Nordisk A/S, and GE Capital IT Solutions. Educational background includes ongoing studies at the University of Toronto and attendance at Sheridan College.
This person is not in any teams
This person is not in any offices
Juno Pharmaceuticals Canada
Juno Pharmaceuticals Canada sources, develops, and delivers life saving specialized pharmaceutical products for Canadian patients. Our colleagues work with trusted partners to co-develop novel drug delivery mechanisms that satisfy untapped market demand, first to market generic products, biosimilar offerings, and patent challenge strategies. Juno’s portfolio consists of both branded and generic drug assets in multiple presentation forms including injectable drugs (vials, amps, & pre filled syringes), complex biosimilars, ophthalmic products, oral does tablets and capsules, prescription dermatology topicals, and other unique dosage systems. Our team have deep roots into the Canadian hospital space, retail pharmacy market, specialty channels, and a robust B2B platform. In addition, Juno Canada has recently embarked with product sourcing in the animal health space and remain focused on opening new delivery channels and customer groups to facilitate supply for Canadian patients. Juno is proud to supply 5 molecules deemed medically necessary by the World Health Organization on their critically essential medications list, and we are actively pursuing export opportunities to countries in need of our critical medications. To learn more about Juno Pharmaceuticals Canada please contact us at communications@junopharm.com For sales enquiries contact us at sales@junopharm.com